title: "Cold" single-strand conformational variants for mutation analysis of the RET protooncogene.
abstract: BACKGROUND
  RET protooncogene mutation analysis is a routinely performed predictive DNA test in kindreds affected by multiple endocrine neoplasia (MEN) types 2A and 2B and familial medullary thyroid carcinoma (FMTC), and is a valuable diagnostic tool in newly diagnosed cases of medullary thyroid carcinoma (MTC).
  
  
  METHODS
  We tested the suitability of the recently introduced "cold" single-strand conformational variant (SSCV) technique, which promises rapid, simple, nonradioactive detection of sequence variants in the identification of germline and somatic RET mutations. A total of 11 different mutations in exon 10 (codons 609, 611, 618, and 620) and 6 mutations in exon 11 (codon 634) were studied.
  
  
  RESULTS
  Conditions were optimized so that conformational variants were demonstrated for all mutations examined in a single setting for exons 10 and 11. A novel six base pair (bp) inframe deletion between cysteines 630 and 634 was detected in a sporadic MTC. This adds to the evidence that not only cysteine deletions and substitutions but also changes in the spacing between cysteine residues have a pathogenic effect.
  
  
  CONCLUSIONS
  Our results indicate that the cold SSCV method offers the advantages of simplicity, time savings, and nonradioactive detection for screening for RET sequence variants in hereditary and sporadic MTCs.
authors.affiliation: Department of Surgery, Washington University School of Medicine, St. Louis, Mo. 63110, USA.
authors.forename: P B
authors.initials: PB
authors.lastname: Musholt
authors.forename: T J
authors.initials: TJ
authors.lastname: Musholt
authors.forename: P J
authors.initials: PJ
authors.lastname: Goodfellow
authors.forename: B A
authors.initials: BA
authors.lastname: Zehnbauer
authors.forename: S A
authors.initials: SA
authors.lastname: Wells
authors.forename: J F
authors.initials: JF
authors.lastname: Moley
mesh_terms: D000595:Amino Acid Sequence; D001483:Base Sequence; D018276:Carcinoma, Medullary / Q000235:genetics*; D003062:Codon; D004247:DNA / Q000097:blood; D029721:Drosophila Proteins; D005091:Exons; D014644:Genetic Variation; D006801:Humans; D018813:Multiple Endocrine Neoplasia Type 2a / Q000235:genetics*; D018814:Multiple Endocrine Neoplasia Type 2b / Q000235:genetics*; D017354:Point Mutation; D018807:Polymorphism, Single-Stranded Conformational; D011237:Predictive Value of Tests; D011336:Probability; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis / Q000737:chemistry / Q000235:genetics*; D051096:Proto-Oncogene Proteins c-ret; D011519:Proto-Oncogenes; D020794:Receptor Protein-Tyrosine Kinases / Q000096:biosynthesis / Q000737:chemistry / Q000235:genetics*; D015183:Restriction Mapping; D013964:Thyroid Neoplasms / Q000235:genetics*
chemical_list: D003062:Codon; D029721:Drosophila Proteins; D011518:Proto-Oncogene Proteins; D004247:DNA; D051096:Proto-Oncogene Proteins c-ret; D020794:Receptor Protein-Tyrosine Kinases; C416649:Ret protein, Drosophila